SPIE SA (SPIE.PA)

FR0012757854 - Common Stock

36.04  +0.26 (+0.73%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SPIE. SPIE was compared to 44 industry peers in the Commercial Services & Supplies industry. SPIE has a medium profitability rating, but doesn't score so well on its financial health evaluation. SPIE is not valued too expensively and it also shows a decent growth rate.



6

1. Profitability

1.1 Basic Checks

SPIE had positive earnings in the past year.
In the past year SPIE had a positive cash flow from operations.
SPIE had positive earnings in each of the past 5 years.
SPIE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

SPIE has a Return On Assets of 2.61%. This is in the better half of the industry: SPIE outperforms 60.98% of its industry peers.
The Return On Equity of SPIE (12.22%) is better than 63.41% of its industry peers.
SPIE has a Return On Invested Capital (5.94%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SPIE is below the industry average of 9.08%.
The last Return On Invested Capital (5.94%) for SPIE is above the 3 year average (5.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.61%
ROE 12.22%
ROIC 5.94%
ROA(3y)2.09%
ROA(5y)1.75%
ROE(3y)10.11%
ROE(5y)8.83%
ROIC(3y)5.25%
ROIC(5y)4.73%

1.3 Margins

With a Profit Margin value of 2.73%, SPIE perfoms like the industry average, outperforming 56.10% of the companies in the same industry.
In the last couple of years the Profit Margin of SPIE has grown nicely.
SPIE has a Operating Margin (5.38%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SPIE has grown nicely.
SPIE's Gross Margin of 42.82% is in line compared to the rest of the industry. SPIE outperforms 48.78% of its industry peers.
In the last couple of years the Gross Margin of SPIE has remained more or less at the same level.
Industry RankSector Rank
OM 5.38%
PM (TTM) 2.73%
GM 42.82%
OM growth 3Y13.03%
OM growth 5Y5.09%
PM growth 3Y50.68%
PM growth 5Y14.88%
GM growth 3Y-1.1%
GM growth 5Y1.3%

2

2. Health

2.1 Basic Checks

SPIE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SPIE has more shares outstanding
Compared to 5 years ago, SPIE has more shares outstanding
Compared to 1 year ago, SPIE has an improved debt to assets ratio.

2.2 Solvency

SPIE has an Altman-Z score of 1.66. This is a bad value and indicates that SPIE is not financially healthy and even has some risk of bankruptcy.
SPIE has a Altman-Z score (1.66) which is in line with its industry peers.
The Debt to FCF ratio of SPIE is 3.82, which is a good value as it means it would take SPIE, 3.82 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.82, SPIE is doing good in the industry, outperforming 75.61% of the companies in the same industry.
SPIE has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SPIE (1.05) is worse than 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF 3.82
Altman-Z 1.66
ROIC/WACC0.92
WACC6.44%

2.3 Liquidity

A Current Ratio of 0.92 indicates that SPIE may have some problems paying its short term obligations.
SPIE has a Current ratio of 0.92. This is in the lower half of the industry: SPIE underperforms 75.61% of its industry peers.
SPIE has a Quick Ratio of 0.92. This is a bad value and indicates that SPIE is not financially healthy enough and could expect problems in meeting its short term obligations.
SPIE has a Quick ratio of 0.91. This is in the lower half of the industry: SPIE underperforms 63.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.91

5

3. Growth

3.1 Past

SPIE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.46%, which is quite impressive.
The Earnings Per Share has been growing by 19.93% on average over the past years. This is quite good.
SPIE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.54%.
Measured over the past years, SPIE shows a small growth in Revenue. The Revenue has been growing by 5.44% on average per year.
EPS 1Y (TTM)55.46%
EPS 3Y61.76%
EPS 5Y19.93%
EPS Q2Q%106.29%
Revenue 1Y (TTM)7.54%
Revenue growth 3Y9.43%
Revenue growth 5Y5.44%
Sales Q2Q%-43.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.49% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.18% on average over the next years.
EPS Next Y20.82%
EPS Next 2Y15.51%
EPS Next 3Y12.49%
EPS Next 5YN/A
Revenue Next Year13.62%
Revenue Next 2Y9.95%
Revenue Next 3Y8.15%
Revenue Next 5Y5.18%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.20, which means the current valuation is very expensive for SPIE.
Compared to the rest of the industry, the Price/Earnings ratio of SPIE is on the same level as its industry peers.
SPIE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.41, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 14.07, the valuation of SPIE can be described as correct.
SPIE's Price/Forward Earnings ratio is in line with the industry average.
SPIE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.59.
Industry RankSector Rank
PE 25.2
Fwd PE 14.07

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPIE is valued a bit more expensive than the industry average as 63.41% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as SPIE.
Industry RankSector Rank
P/FCF 9.23
EV/EBITDA 9.33

4.3 Compensation for Growth

SPIE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of SPIE may justify a higher PE ratio.
SPIE's earnings are expected to grow with 12.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.21
PEG (5Y)1.26
EPS Next 2Y15.51%
EPS Next 3Y12.49%

6

5. Dividend

5.1 Amount

SPIE has a Yearly Dividend Yield of 2.30%. Purely for dividend investing, there may be better candidates out there.
SPIE's Dividend Yield is a higher than the industry average which is at 3.69.
SPIE's Dividend Yield is comparable with the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

The dividend of SPIE is nicely growing with an annual growth rate of 6.15%!
Dividend Growth(5Y)6.15%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

SPIE pays out 53.13% of its income as dividend. This is a bit on the high side, but may be sustainable.
SPIE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP53.13%
EPS Next 2Y15.51%
EPS Next 3Y12.49%

SPIE SA

EPA:SPIE (7/26/2024, 7:00:00 PM)

36.04

+0.26 (+0.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.02B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 25.2
Fwd PE 14.07
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.21
PEG (5Y)1.26
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 12.22%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.38%
PM (TTM) 2.73%
GM 42.82%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.92
Quick Ratio 0.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)55.46%
EPS 3Y61.76%
EPS 5Y
EPS Q2Q%
EPS Next Y20.82%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.54%
Revenue growth 3Y9.43%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y